Honduras currently reports a female mortality from cvd, cancer, diabetes or crd between exact ages 30 and 70 of 17.1%, a decrease of 1.8% (-9.5%) from 2020.
Female mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 in Honduras
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2021
Points:
13,975
Measure:
%
More indicators for Honduras
Out-of-pocket expenditure PPP per capita
intl dollar284
-intl dollar7
(2022)
Newborns protected against tetanus
99%
0%
(2023)
Female wasting in children
1.8%
+0.9%
(2019)
Birth registration
97%
+3.4%
(2019)
Female prevalence of HIV
0.1%
0%
(2022)
Contraceptive modern method prevalence
66.5%
+2.7%
(2019)
Honduras Female CVD, cancer, diabetes or CRD between 2000 and 2021
Period | Value | Change |
---|---|---|
2021 | 17.1% | -1.8% |
2020 | 18.9% | -1.6% |
2019 | 20.5% | -0.1% |
2018 | 20.6% | -0.5% |
2017 | 21.1% | +0.1% |
2016 | 21% | -0.5% |
2015 | 21.5% | +0.2% |
2014 | 21.3% | +0.1% |
2013 | 21.2% | +0.1% |
2012 | 21.1% | +1.6% |
2011 | 19.5% | +0.3% |
2010 | 19.2% | +0.1% |
2009 | 19.1% | -0.1% |
2008 | 19.2% | 0% |
2007 | 19.2% | -0.1% |
2006 | 19.3% | +0.1% |
2005 | 19.2% | +0.2% |
2004 | 19% | +0.4% |
2003 | 18.6% | +0.4% |
2002 | 18.2% | 0% |
2001 | 18.2% | +0.1% |
2000 | 18.1% |